drugset / Trial / NCT04290897
Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors
Phase 2
Completed
18 enrolled
Jonsson Comprehensive Cancer Center
Breast Cancer Research Foundation · collabMetVital, Inc. · collab
NaSingle-groupOpen-labelSupportive care
Summary
This phase II trial studies how well oxaloacetate works in reducing cognitive complaints in stage 0-IIIA breast cancer survivors. Oxaloacetate is a natural substance found in the body and is available as a nutritional supplement. Giving oxaloacetate may reduce inflammation in the brain that could be contributing to cognitive complaints seen after cancer treatments.
Timeline
- Start
- 2021-09-29
- Primary completion
- 2024-11-12
- Completion
- 2024-11-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaloacetate | Unknown | — | Oral |